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Susan S. Witte, PhD, Colleen MacPhee, MSW, Natalie Ginsburg, MSW, and Neha Deshmukh, MSW
Objectives.To examine state-level female condomuse throughMedicaid from2004 to
2014, because in 2010, the Patient Protection and Affordable Care Act (ACA) allowed for
expanded Medicaid coverage in many states, extending requirements for contraceptive
care tomore of the poorestwomen in theUnited States and tomostwomenwith private
insurance.
Methods.Wecollecteddata via brief surveyofMedicaidoffices in all 50 states between
March 2015 and March 2016.
Results. The number of states providing Medicaid reimbursement for the female
condom increased 33% (from 25 to 36) since 2007. Twenty-nine states provided data
showing low numbers of claims for female condoms but high rates of reimbursement.
Conclusions. This period of heightened access demands that the public health com-
munity seize themoment to increase awareness about and promote the female condom
among health care professionals and consumers. The pending repeal of the ACA may
thwart important gains in access; policies promoting women’s reproductive health must
be implemented immediately. (Am J Public Health. 2017;107:1633–1635. doi:10.2105/
AJPH.2017.303936)
In the promotion of women’s reproductivehealth, the prevention of unintended
pregnancy and of sexually transmitted in-
fections, including HIV, is a high priority. In
2015, 87%of newly diagnosedHIV infections
among women in the United States were
from heterosexual transmission,1 with poor
and low-income women disproportionately
represented.2 Although unintended preg-
nancy has declined overall in the United
States over the past 2 decades, it also has
become increasingly concentrated among
poor and low-income women.3 Medicaid
plays a primary role in facilitating access to
reproductive health services and financing
health care for poor US women. Women
represent approximately 25% of HIV-
infected individuals in the United States
but 41% of HIV-infected Medicaid
beneficiaries.4,5
As the only female-initiated barrier
method and because gender inequities may
deprive women of control over reproductive
health decisions, the female condom is an
essential option for women. Yet studies
consistently report that its rate of use in the
United States remains low, and concerns
persist about the accessibility of the device.2
For more than 2 decades, the female
condom has been a reimbursable, over-the-
counter device for traditional Medicaid re-
cipients in many states.6 It also has been
available in some states with family plan-
ning “expansion programs,” addressing
low-income women who are not eligible
for full-benefit Medicaid. The Patient
Protection and Affordable Care Act (ACA;
Pub L No. 111–148), passed in 2009 and
signed into law in 2010, included 2
changes, 1 associated with Medicaid, that
should have increased access to the female
condom. First, it gave states the option to
expand Medicaid coverage, making con-
traception more readily available. Second, it
required that all contraceptive options ap-
proved by the US Food and Drug Admin-
istration be covered by insurance providers
under preventive services for women at no
cost either over the counter or with a pre-
scription.7 With the ACA expansion, 3
contraceptive coverage pathways for
Medicaid-eligible individuals are now
available (traditional Medicaid available
before the ACA, the Medicaid family
planning program, and the ACA Medicaid
expansion) within each state. These multiple
pathways to coverage have made it difficult
to assess whether and where individuals may
access the female condom viaMedicaid. The
only available survey detailing the states’
commonalities and differences on contra-
ceptive coverage included 40 states8 but
unfortunately did not ask about the female
condom.
We examined state-level access to and use
of the female condom through Medicaid
from 2004 to 2014, including the years since
passage of the ACA. We update data from an
earlier survey that examined Medicaid re-
imbursement for the female condom through
2007.
METHODS
We replicated protocols from our earlier
study examining female condom use via
Medicaid by state through 2007.6 Briefly, we
collected data by telephone and e-mail,
using a script, from each of the 50 state
Medicaid offices individually between
March 2015 and March 2016.6 When initial
contacts were unable to provide data, we
asked for additional contacts from whomwe
might request data.
We asked the Medicaid representatives 3
questions: (1) How many claims for female
condoms have been made by consumers each
year from 2004 to 2014?; (2) How many
female condom units were distributed in
response to these claims?; and (3) What was
the total spending in dollars for female
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condoms requested through Medicaid?
Contact attempts continued until (1) we
obtained data, (2) we were told that the
data could not or would not be provided,
(3) we were told that the data would require
payment in excess of $100, or (4) we
were told that the state did not reimburse
for the device.
RESULTS
Figure 1 illustrates the Medicaid re-
imbursement status for the female condom
in each state. Of the 50 states, 36 (72%)
reported that they currently provide re-
imbursement. Four states that reported
“yes” to reimbursement in 2007 (Arkansas,
Florida, Utah, Vermont) and 1 state that we
could not contact in 2007 (Delaware) re-
ported that they do not and never did re-
imburse for the female condom. Nine states
reported reimbursement through Medicaid
for the first time since 20076: Connecticut,
Idaho, Kansas, Kentucky, Maine, New
Jersey, Oregon, South Carolina, and
Wyoming.
Fourteen states, many in the Southeast,
reported that they do not provide Medicaid
reimbursement for the female condom.
Beginning dates of coverage varied
throughout the United States; some states
(e.g., Mississippi and Colorado) said that they
would begin coverage “soon.”
Two additional data tables (available as
supplements to the online version of this
article at http://www.ajph.org) provide in-
dividual and summary data from 29 (81%) of
the 36 states reporting reimbursement. Table
A shows considerable variance in reporting of
data and in claims per year across states. Some
states provided comprehensive data across the
study period; others reported data for only
1 or 2 years. Some states had thousands of
claims, whereas others had few to none. Some
states reimbursed hundreds of thousands of
dollars, but others reimbursed less than $10
per year. In 2007, Iowa, Michigan, and
Nevada showed steady increases in re-
imbursement,whereasmore recent data show
increases in some states (Iowa, Oregon,
Pennsylvania) but steady decreases in others
(Michigan, Minnesota, New York). Claims
and reimbursement numbers do not neces-
sarily correspondwith relative state-levelHIV
prevalence or rates of unintended pregnancy.
Table B shows cumulative claims at their
highest in 2010, just before ACA passage, and
declining after the 2012 contraceptive
expansion.
DISCUSSION
The number of states providing Medicaid
reimbursement for the female condom in-
creased 33% (from 25 to 36) since 2007.6
Findings suggest that the ACA expansion
increased access throughMedicaid.However,
reported use in states providing re-
imbursement remains uneven, and data col-
lection and reporting challenges persist.
The varying numbers of claims may reflect
the unevenness in Medicaid expansion; in
2012, the Supreme Court determined that
states could opt out of that expansion.Only in
the last 5 to 10 years have many states assigned
a unique Medicaid code to distinguish female
from male condoms, which affects the count
in data searches. A more likely reason is
providers’ persistent lack of awareness of the
device or lack of willingness to recommend or
prescribe it or a lack of awareness among
consumers about their ability to request it.2,9
One interpretive challenge is that utiliza-
tion datamay not accurately reflect claims and
costs because some states and programs have
an established or negotiated payment to
managed care organizations, called capitation,
which allows provision of numerous services
for 1 annual fee. Therefore, decreases in
claims in some states may not reflect fewer
distributed female condoms.
PUBLIC HEALTH IMPLICATIONS
TheACAhas theoretically increased access
to the female condom for most women re-
ceiving Medicaid and all women with private
insurance free of charge. Getting the device
into the hands ofwomen, however, is another
matter. This period of heightened access
demands that the public health community
seize themoment to increase awareness about
and promote the female condom among
health care professionals and consumers.
Apparently, female condoms are seldom
claimed or reimbursed through Medicaid.
We must spread awareness of the device,
promote increases in provider prescriptions,
and reduce persistent barriers to its use. In-
creasing access in states with higher HIV
prevalence and unintended pregnancies may
contribute to further reductions in the
transmission of HIV and other sexually
transmitted infections and also reduce
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FIGURE 1—State Medicaid Program Reimbursement for the Female Condom: United States,
2014
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unintended pregnancies. The pending repeal
of the ACA may thwart important gains
in access; policies promoting women’s re-
productive health must be implemented
immediately.
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